抗肿瘤抗原的L2A5抗体或其功能性片段

Paula Alexandra Quintela Videira; Carlos Manuel Mendes Novo; Liliana Raquel Rodrigues  Loureiro; Mylene Adelaide do Rosário Carrascal; José Alexandre Ribeiro de Castro  Ferreira; Maria Angelina de Sá Palma; Lucio Lara Santos; Luis Carlos Oliveira LIma; Wengang Chai; Michael  Philippe  Bachmann

抗肿瘤抗原的L2A5抗体或其功能性片段

Translated title of the contribution: L2A5 ANTIBODY OR FUNCTIONAL FRAGMENT THEREOF AGAINST TUMOUR ANTIGENS

Paula Alexandra Quintela Videira (Inventor), Carlos Manuel Mendes Novo (Inventor), Liliana Raquel Rodrigues Loureiro (Inventor), Mylene Adelaide do Rosário Carrascal (Inventor), José Alexandre Ribeiro de Castro Ferreira (Inventor), Maria Angelina de Sá Palma (Inventor), Lucio Lara Santos (Inventor), Luis Carlos Oliveira LIma (Inventor), Wengang Chai (Inventor), Michael Philippe Bachmann (Inventor)

Research output: Patent › Regional/Other National Application

Abstract

This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/ amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.

Translated title of the contribution	L2A5 ANTIBODY OR FUNCTIONAL FRAGMENT THEREOF AGAINST TUMOUR ANTIGENS
Original language	Chinese (Traditional)
Patent number	CN113287018
IPC	G01N 33/ 574 A I
Priority date	17/01/19
Filing date	25/09/20
Publication status	Published - 20 Aug 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{7a5c328a0a7f4927a879805e007f7a14,

title = "抗肿瘤抗原的L2A5抗体或其功能性片段",

abstract = "This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/ amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.",

author = "Videira, {Paula Alexandra Quintela} and Novo, {Carlos Manuel Mendes} and Loureiro, {Liliana Raquel Rodrigues} and Carrascal, {Mylene Adelaide do Ros{\'a}rio} and Ferreira, {Jos{\'e} Alexandre Ribeiro de Castro} and Palma, {Maria Angelina de S{\'a}} and Santos, {Lucio Lara} and LIma, {Luis Carlos Oliveira} and Wengang Chai and Bachmann, {Michael Philippe}",

year = "2021",

month = aug,

day = "20",

language = "Chinese (Traditional)",

type = "Patent",

note = "CN113287018; G01N 33/ 574 A I",

}

TY - PAT

T1 - 抗肿瘤抗原的L2A5抗体或其功能性片段

AU - Videira, Paula Alexandra Quintela

AU - Novo, Carlos Manuel Mendes

AU - Loureiro, Liliana Raquel Rodrigues

AU - Carrascal, Mylene Adelaide do Rosário

AU - Ferreira, José Alexandre Ribeiro de Castro

AU - Palma, Maria Angelina de Sá

AU - Santos, Lucio Lara

AU - LIma, Luis Carlos Oliveira

AU - Chai, Wengang

AU - Bachmann, Michael Philippe

PY - 2021/8/20

Y1 - 2021/8/20

N2 - This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/ amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.

AB - This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/ amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.

M3 - Regional/Other National Application

M1 - CN113287018

Y2 - 2020/09/25

ER -

抗肿瘤抗原的L2A5抗体或其功能性片段

Abstract

UN SDGs

Fingerprint

Cite this